Stocks · Health care · Services-Commercial Physical & Biological Research

OmniAb, Inc.

OABI Clue Score25
United States Fiscal year ends December CIK 0001846253 Results filed 30 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
John L Higgins
7 Nov 2025
Director
Buy
41,038
$1.38
$56.63K
John L Higgins
6 Nov 2025
Director
Buy
36,223
$1.41
$51.07K
Jennifer R. Cochran
15 May 2025
Director
Buy
30,000
$1.52
$45.60K
Steven Love
14 May 2025
Director
Buy
25,000
$1.46
$36.50K
John L Higgins
12 May 2025
Director
Buy
65,000
$1.44
$93.60K
John L Higgins
21 Mar 2025
Director
Buy
4,000
$2.28
$9.12K
John L Higgins
20 Mar 2025
Director
Buy
125,750
$2.35
$295.51K
Matthew W Foehr
24 May 2024
President and CEO
Buy
240,000
$4.42
$1.06M
Matthew W Foehr
22 Mar 2024
President and CEO
Buy
225,000
$5.19
$1.17M
Matthew W Foehr
12 Dec 2023
Chief Executive Officer
Buy
200,000
$5.05
$1.01M
Matthew W Foehr
10 Nov 2023
President and CEO
Buy
95,000
$4.27
$405.52K
Matthew W Foehr
14 Aug 2023
President and CEO
Buy
45,000
$5.48
$246.60K
Matthew W Foehr
9 Jun 2023
Chief Executive Officer
Buy
115,000
$4.52
$519.80K
Matthew W Foehr
12 May 2023
Chief Executive Officer
Buy
440,000
$3.40
$1.50M
Matthew W Foehr
12 Dec 2022
President & CEO
Buy
150,000
$3.77
$564.77K
Jennifer R. Cochran
6 Dec 2022
Director
Buy
22,250
$3.75
$83.53K
Matthew W Foehr
30 Nov 2022
President & CEO
Buy
300,000
$3.39
$1.02M
Kurt A Gustafson
28 Nov 2022
EVP, Finance and CFO
Buy
10,000
$2.81
$28.10K
Jennifer R. Cochran
11 Nov 2022
Director
Buy
30,000
$3.10
$92.93K
Sarah Boyce
10 Nov 2022
Director
Buy indirect
15,000
$2.92
$43.80K
Matthew W Foehr
9 Nov 2022
President & CEO
Buy
100,000
$2.76
$276.16K
Sunil Patel
9 Nov 2022
Director
Buy
43,000
$2.77
$119.11K
Sarah Boyce
9 Nov 2022
Director
Buy indirect
21,000
$2.74
$57.60K

What was left out

Form 4 filings counted 142
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 14
Sales at will 19
Transactions with no price 0
Shares from compensation/vesting 49,829,295
History held since 3 Nov 2022